Seeing Is Believing

Currently out of the existing stock ratings of Chris Howerton, 107 are a BUY (75.89%), 30 are a HOLD (21.28%), 4 are a SELL (2.84%).
Analyst Chris Howerton, carries an average stock price target met ratio of 56.7% that have a potential upside of 37.18% achieved within 271 days. Previously, Chris Howerton worked at JEFFERIES.
Chris Howerton’s has documented 282 price targets and ratings displayed on 44 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VNDA, Vanda Pharmaceuticals at 31-Dec-2025.
Analyst best performing recommendations are on PSTI (PLURISTEM).
The best stock recommendation documented was for PSTI (PLURISTEM) at 12/10/2020. The price target of $6 was fulfilled within 1 day with a profit of $0.22 (3.54%) receiving and performance score of 35.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Oct-2023
$34
$13.26 (63.93%)
$31
17 days ago
(04-Mar-2026)
8/15 (53.33%)
$11.5 (51.11%)
113
Buy Since 26-Jun-2025
$30
$9.26 (44.65%)
$31
23 days ago
(26-Feb-2026)
0/6 (0%)
$5.03 (20.14%)
Buy Since 07-Aug-2015
$37
$16.26 (78.40%)
$35
23 days ago
(26-Feb-2026)
7/16 (43.75%)
$12.03 (48.18%)
671
Hold Since 03-Nov-2022
$24
$3.26 (15.72%)
$25
23 days ago
(26-Feb-2026)
19/22 (86.36%)
$-0.97 (-3.88%)
112
Hold Since 08-Oct-2025
$35
$14.26 (68.76%)
$29
26 days ago
(23-Feb-2026)
1/3 (33.33%)
$11.01 (45.89%)
35
Which stock is Chris Howerton is most bullish on?
Which stock is Chris Howerton is most reserved on?
What Year was the first public recommendation made by Chris Howerton?